Craft

Lupin

Stock Price

₹2.2 K

2024-10-29

Market Capitalization

₹1 T

2024-10-29

Revenue

₹274.9 B

FY, 2026

Lupin Summary

Company Summary

Overview
Lupin is a company that specializes in the manufacture of pharmaceutical products. It covers anti-tuberculosis, diabetes management, cardiac care, respiratory, women’s health, and central nervous system areas. The company offers branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients.
Type
Public
Status
Active
Founded
1968
HQ
Mumbai, IN | view all locations
Website
https://www.lupin.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Manju D Gupta

    Manju D Gupta, Chairman

    • Vinita Gupta

      Vinita Gupta, Chief Executive Officer, Director

      • Cyrus Karkaria

        Cyrus Karkaria, President – Biotechnology

      • Nilesh D Gupta

        Nilesh D Gupta, Managing Director

        Operating MetricsView all

        Suppliers (Tier 1)

        9.4K
        9.2%

        FY, 2024

        Critical Suppliers (Non-Tier 1)

        22

        FY, 2024

        Countries (Patients)

        100

        FY, 2024

        LocationsView all

        19 locations detected

        • Mumbai, MH HQ

          India

          3rd Floor, Kalpataru Inspire, Off. Western Expressway Highway, Santacruz (East)

        • Baltimore, MD

          United States

          Harborplace Tower 111 South Calvert Street 21st Floor

        • Blue Bell, PA

          United States

          325 Sentry Pkwy

        • Coral Springs, FL

          United States

          4006 NW 124th Ave

        • Franklin, NJ

          United States

          400 Campus Dr, Somerset

        • Naples, FL

          United States

          5801 Pelican Bay Blvd # 500

        and 13 others

        Lupin Financials

        Summary Financials

        Revenue (FY, 2026)
        ₹274.9B
        Gross profit (FY, 2026)
        ₹210.6B
        Net income (FY, 2026)
        ₹53.6B
        Cash (FY, 2026)
        ₹56.5B
        EBIT (FY, 2026)
        ₹66.5B
        Enterprise value
        $1.0T

        Footer menu